These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36668869)

  • 21. Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy - Australian Snakebite Project (ASP-25).
    Johnston CI; Ryan NM; O'Leary MA; Brown SG; Isbister GK
    Clin Toxicol (Phila); 2017 Feb; 55(2):115-122. PubMed ID: 27903075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxin-centric development approach for next-generation antivenoms.
    Laustsen AH
    Toxicon; 2018 Aug; 150():195-197. PubMed ID: 29857088
    [No Abstract]   [Full Text] [Related]  

  • 23. Death adder envenoming causes neurotoxicity not reversed by antivenom--Australian Snakebite Project (ASP-16).
    Johnston CI; O'Leary MA; Brown SG; Currie BJ; Halkidis L; Whitaker R; Close B; Isbister GK;
    PLoS Negl Trop Dis; 2012; 6(9):e1841. PubMed ID: 23029595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antivenom efficacy or effectiveness: the Australian experience.
    Isbister GK
    Toxicology; 2010 Feb; 268(3):148-54. PubMed ID: 19782716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antivenom: An immunotherapy for the treatment of snakebite envenoming in sub-Saharan Africa.
    Mender MM; Bolton F; Berry C; Young M
    Adv Protein Chem Struct Biol; 2022; 129():435-477. PubMed ID: 35305724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral Complications of Snakebite Envenoming: Case Studies.
    Huang YK; Chen YC; Liu CC; Cheng HC; Tu AT; Chang KC
    Toxins (Basel); 2022 Jun; 14(7):. PubMed ID: 35878174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Snakebite in Australia: a practical approach to diagnosis and treatment.
    Isbister GK; Brown SG; Page CB; McCoubrie DL; Greene SL; Buckley NA
    Med J Aust; 2013 Dec; 199(11):763-8. PubMed ID: 24329653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuromuscular and Clinical Recovery in Thoracic Surgical Patients Reversed With Neostigmine or Sugammadex.
    Murphy GS; Avram MJ; Greenberg SB; Bilimoria S; Benson J; Maher CE; Teister KJ; Szokol JW
    Anesth Analg; 2021 Aug; 133(2):435-444. PubMed ID: 33323787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two rare case reports of confirmed Ceylon krait (Bungarus ceylonicus) envenoming in Sri Lanka.
    Namal Rathnayaka RM; Kularatne SA; Kumarasinghe KD; Jeganadan K; Ranathunga PE
    Toxicon; 2017 Mar; 127():44-48. PubMed ID: 28062164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe Snakebite Envenoming in Intensive Care.
    Valenta J; Stach Z; Michálek P
    Prague Med Rep; 2016; 117(4):153-163. PubMed ID: 27930893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Varespladib (LY315920) rescued mice from fatal neurotoxicity caused by venoms of five major Asiatic kraits (Bungarus spp.) in an experimental envenoming and rescue model.
    Tan CH; Lingam TMC; Tan KY
    Acta Trop; 2022 Mar; 227():106289. PubMed ID: 34929179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Urgent Need to Develop Novel Strategies for the Diagnosis and Treatment of Snakebites.
    Williams HF; Layfield HJ; Vallance T; Patel K; Bicknell AB; Trim SA; Vaiyapuri S
    Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31226842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of snakebite in Australia: the current evidence base and questions requiring collaborative multicentre prospective studies.
    Currie BJ
    Toxicon; 2006 Dec; 48(7):941-56. PubMed ID: 16930660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advancements in snake antivenom production.
    Rathore AS; Kumar R; Tiwari OS
    Int J Biol Macromol; 2023 Jun; 240():124478. PubMed ID: 37072061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vellozia flavicans Mart. ex Schult. hydroalcoholic extract inhibits the neuromuscular blockade induced by Bothrops jararacussu venom.
    Tribuiani N; da Silva AM; Ferraz MC; Silva MG; Bentes AP; Graziano TS; dos Santos MG; Cogo JC; Varanda EA; Groppo FC; Cogo K; Oshima-Franco Y
    BMC Complement Altern Med; 2014 Feb; 14():48. PubMed ID: 24507387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrating Engineering, Manufacturing, and Regulatory Considerations in the Development of Novel Antivenoms.
    Laustsen AH; Dorrestijn N
    Toxins (Basel); 2018 Jul; 10(8):. PubMed ID: 30065185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antivenom for European Vipera species envenoming.
    Lamb T; de Haro L; Lonati D; Brvar M; Eddleston M
    Clin Toxicol (Phila); 2017 Jul; 55(6):557-568. PubMed ID: 28349771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Preclinical Evaluation of a Second-Generation Antivenom for Treating Snake Envenoming in India.
    Attarde S; Iyer A; Khochare S; Shaligram U; Vikharankar M; Sunagar K
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current treatment for venom-induced consumption coagulopathy resulting from snakebite.
    Maduwage K; Isbister GK
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3220. PubMed ID: 25340841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antivenoms for snakebite envenomings.
    Gutiérrez JM; León G; Lomonte B; Angulo Y
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):369-80. PubMed ID: 21745181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.